TRPV1 and Schnyder corneal dystrophy: Oral administration to SCD mice of the TRPV1 agonist, capsaicin, which activates somatosensory nerves through TRPV1 binding, was shown to dramatically alleviate acute vaso‐occlusive events and to significantly reduce ensuing chronic liver and kidney damage.4